92 related articles for article (PubMed ID: 760100)
1. [Absorption of anti-tuberculous drugs after gastric surgery (author's transl)].
Kleber FX
Prax Klin Pneumol; 1979 Jan; 33(1):38-44. PubMed ID: 760100
[TBL] [Abstract][Full Text] [Related]
2. Relative bioavailability of rifampicin, isoniazid and ethambutol from a combination tablet vs. concomitant administration of a capsule containing rifampicin and a tablet containing isoniazid and ethambutol.
Schall R; Müller FO; Duursema L; Groenewoud G; Hundt HK; Middle MV; Mogilnicka EM; Swart KJ
Arzneimittelforschung; 1995 Nov; 45(11):1236-9. PubMed ID: 8929247
[TBL] [Abstract][Full Text] [Related]
3. [Pharmacokinetics and metabolism of the principal antubercular drugs].
Malègue D; Tillement JP
Rev Prat; 1979 Jun; 29(33):2629-40. PubMed ID: 482817
[No Abstract] [Full Text] [Related]
4. [Clinical problems on the binding of protein to antituberculous drugs (author's transl)].
Aoyagi T
Kekkaku; 1977 Sep; 52(9):459-68. PubMed ID: 916498
[No Abstract] [Full Text] [Related]
5. Absorption of sulphonamides and antitubercular drugs from the rat lung.
Burton JA; Schanker LS
Xenobiotica; 1974 May; 4(5):291-6. PubMed ID: 4407063
[No Abstract] [Full Text] [Related]
6. [Resorption of fats and carbohydrates following stomach resection and gastrectomy].
Stallkamp B; Häring R; Hahn W; Schürnbrand P; Tung LC
Langenbecks Arch Chir; 1976; Suppl():253-6. PubMed ID: 1031811
[TBL] [Abstract][Full Text] [Related]
7. [Modification during treatment of the rate of acetylation of isoniazide clinically or biologically detectable hepatic damage (author's transl)].
Albengres E; Houin G; Breau JL; Hirsch A; Saltiel JC; Tillement JP; Chrétien J
Nouv Presse Med; 1977 Oct; 6(32):2869-71. PubMed ID: 917803
[TBL] [Abstract][Full Text] [Related]
8. [Controlled trial of isoniazid.rifampicin.ethambutol regimen and isoniazid.rifampicin.pyrazinamide regimen in the primary chemotherapy for pulmonary tuberculosis (author's transl)].
Kekkaku; 1980 Jan; 55(1):7-13. PubMed ID: 6988627
[No Abstract] [Full Text] [Related]
9. [The experimental study on the transmission of the antituberculous drugs to fetuses (author's transl)].
Toyoara M
Kekkaku; 1974 Apr; 49(4):97-9. PubMed ID: 4411151
[No Abstract] [Full Text] [Related]
10. [Absorption of olive oil and lipolytic activity of intestinal juice in vitro after gastrectomy (author's transl)].
Beńo I; Ovecka M; Chorváthová V
Cesk Gastroenterol Vyz; 1974 Mar; 28(2):100-5. PubMed ID: 4821803
[No Abstract] [Full Text] [Related]
11. Serum concentration and urinary excretion of ethambutol administered alone and in combination with isoniazid in patients of pulmonary tuberculosis.
Singhal KC; Rathi R; Varshney DP; Kishore K
Indian J Physiol Pharmacol; 1985; 29(4):223-6. PubMed ID: 3842376
[TBL] [Abstract][Full Text] [Related]
12. Absorption of rifampicin in gastrectomized patients. Effect of meals.
Hagelund CH; Wåhlén P; Eidsaunet W
Scand J Respir Dis; 1977 Oct; 58(5):241-6. PubMed ID: 601547
[TBL] [Abstract][Full Text] [Related]
13. Bioavailability of rifampicin, isoniazid and pyrazinamide in a triple drug formulation: comparison of plasma and urine kinetics.
Gurumurthy P; Ramachandran G; Vijayalakshmi S; Kumar AK; Venkatesan P; Chandrasekaran V; Vjayasekaran V; Kumaraswami V; Prabhakar R
Int J Tuberc Lung Dis; 1999 Feb; 3(2):119-25. PubMed ID: 10091876
[TBL] [Abstract][Full Text] [Related]
14. Comparative bioavailability of rifampicin, isoniazid and pyrazinamide from a four drug fixed dose combination with separate formulations at the same dose levels.
Agrawal S; Singh I; Kaur KJ; Bhade SR; Kaul CL; Panchagnula R
Int J Pharm; 2004 May; 276(1-2):41-9. PubMed ID: 15113612
[TBL] [Abstract][Full Text] [Related]
15. Mechanistic explanation to the catalysis by pyrazinamide and ethambutol of reaction between rifampicin and isoniazid in anti-TB FDCs.
Bhutani H; Singh S; Jindal KC; Chakraborti AK
J Pharm Biomed Anal; 2005 Oct; 39(5):892-9. PubMed ID: 15978767
[TBL] [Abstract][Full Text] [Related]
16. Does AIDS impair the absorption of antituberculosis agents?
Taylor B; Smith PJ
Int J Tuberc Lung Dis; 1998 Aug; 2(8):670-5. PubMed ID: 9712282
[TBL] [Abstract][Full Text] [Related]
17. The effect of pyrazinamide and rifampicin on isoniazid metabolism in rats.
De Rosa HJ; Baldan HM; Brunetti IL; Ximenes VF; Machado RG
Biopharm Drug Dispos; 2007 Sep; 28(6):291-6. PubMed ID: 17571294
[TBL] [Abstract][Full Text] [Related]
18. A controlled clinical trial of oral short-course regimens in the treatment of sputum-positive pulmonary tuberculosis. Tuberculosis Research Centre.
Int J Tuberc Lung Dis; 1997 Dec; 1(6):509-17. PubMed ID: 9487448
[TBL] [Abstract][Full Text] [Related]
19. Overestimation of rifampicin during colorimetric analysis of anti-tuberculosis products containing isoniazid due to formation of isonicotinyl hydrazone.
Mariappan TT; Jindal KC; Singh S
J Pharm Biomed Anal; 2004 Nov; 36(4):905-8. PubMed ID: 15533688
[TBL] [Abstract][Full Text] [Related]
20. Study of drug resistance in previously treated tuberculosis patients in Gujarat, India.
Shah AR; Agarwal SK; Shah KV
Int J Tuberc Lung Dis; 2002 Dec; 6(12):1098-101. PubMed ID: 12546118
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
